Skip to content

Marcus & Millichap MMI Payments On Stock Appreciation Rights

Payments On Stock Appreciation Rights at other companies

Huntsman logo
HuntsmanHUN
$3M0.0%
GTY
Getty RealtyGTY
$101K-59.9%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$2.5M
Global Net Lease logo
Global Net LeaseGNL
$1.58M
Hexcel logo
HexcelHXL
$300K+109%
Sunbelt Rentals Holdings
 logo
Sunbelt Rentals Holdings SUNB
$4.75M+375%

Other financials

Income statement

See full
Revenue$171.5M+18.2%
Operating income-$5.8M+67.4%
Net income-$3.1M+29.9%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$136.5M-8.8%
Total debt$75.0M-10.6%
Total equity$569.1M-7.9%
Total assets$755.0M-5.9%

Cash flow

See full
Operating cash flow-$27.6M+47.8%
CapEx$3.0M+99.5%
Free cash flow-$30.5M+43.8%

Valuation

See full
Market cap$1.12B-5.0%
Enterprise value$1.06B-4.9%
P/S1.4×-0.2×

Profitability

See full
Gross margin38.1%
Operating margin-9.1%+59.1pp
Net margin-5%-19.8pp
FCF margin10.6%+8.7pp

Returns & leverage

See full
Return on equity-4.9%-44.5pp
Debt / equity0.1×0.0×
Current ratio2.6×-1.1×

Where this comes from

Reported directly by Marcus & Millichap in its filing.

Tagged under the XBRL concept mmi:PaymentsOnStockAppreciationRights.

The official record: Marcus & Millichap’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Marcus & Millichap's payments on stock appreciation rights.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Marcus & Millichap's payments on stock appreciation rights?
Marcus & Millichap (MMI) reported payments on stock appreciation rights of $2.52M in Q1 2026.
How has Marcus & Millichap's payments on stock appreciation rights changed year-over-year?
Marcus & Millichap's payments on stock appreciation rights increased by 12.9% year-over-year, from $2.23M to $2.52M.
What does payments on stock appreciation rights mean?
Reflects cash outflows related to the settlement of stock appreciation rights granted to employees or executives. This metric indicates the cost of equity-based incentive programs that are settled in cash rather than through the issuance of new shares.